University of Iowa Hospitals and Clinics
Participants in this research study have a tumor called malignant peripheral nerve sheath tumor (MPNST) which has not responded to treatment with one or more prior chemotherapy treatments and cannot be completely removed by surgery (unresectable), or has spread to other areas of the body (metastasized). The purpose of this study is to determine how well participants with MPNSTs respond (experience tumor shrinkage or lack of further tumor growth) to treatment with everolimus in combination with bevacizumab. Approximately 5 people will take part in this study conducted by investigators at the University of Iowa. A maximum of 25 people will take part in this study nationwide.
Cindy Robertson 319-356-2778
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.